Shattuck Labs (id:8318 STTK)
1.00 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 6:50:00 PM)
Exchange closed, opens in 14 hours 39 minutes
1.52 USD (1.52%)
-18.29 USD (-18.29%)
-30.69 USD (-30.69%)
-86.67 USD (-86.67%)
-55.53 USD (-55.53%)
-95.43 USD (-95.43%)
About Shattuck Labs
Market Capitalization 60.14M
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
| Headquarters (address) |
500 West 5th Street Austin 78701 TX United States |
| Phone | 512 900 4690 |
| Website | https://www.shattucklabs.com |
| Employees | 75 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | STTK |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 0.940 - 11.76 |
| Market Capitalization | 60.14M |
| P/E trailing | -0.490 |
| P/E forward | -1.18 |
| Price/Sale | 14.58 |
| Price/Book | 0.544 |
| Beta | 1.86 |
| EPS | -1.85 |
| EPS United States (ID:6, base:3402) | 24.22 |